LALIBERTE KEVIN (Sr. VP, Product Development) sold 10.7% of their position (1.39K shares) of DOVA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $22.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/1/2019ACC: 0001209191-19-044032
Officer· Sr. VP, Product Development
Since Jan 2019
+8.61K
Net shares
Net buyer
$22.2K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
10K acquired · 1.39K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.39K
Price / share
$15.97
Trade value
$22.18K
% of position
10.7%
7/31/2019
12.95K→11.56K
Total
Net shares
−1.39K
Net value
-$22.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/31/2019 | S · Sale | −1.39K | $15.97 | $22.18K | 10.7% | 12.95K | 11.56K |
| Total | −1.39K | -$22.18K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
10K shares
Shares
+10K
Strike price
16.08
Held after
10K
Exercisable
—
7/30/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock10K shares | 7/30/2019 | A · Award | +10K | 16.08 | — | 10K |